ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,751,504 | -40.2% | 5,284,386 | -6.3% | 0.01% | -39.1% |
| Q2 2023 | $28,014,329 | -1.7% | 5,636,686 | -2.3% | 0.02% | -8.0% |
| Q1 2023 | $28,498,791 | -8.4% | 5,768,986 | +16.7% | 0.02% | -10.7% |
| Q4 2022 | $31,097,232 | -41.2% | 4,943,916 | +1.0% | 0.03% | -45.1% |
| Q3 2022 | $52,843,000 | -5.1% | 4,892,866 | +0.2% | 0.05% | +2.0% |
| Q2 2022 | $55,666,000 | +24.5% | 4,882,966 | -0.5% | 0.05% | +47.1% |
| Q1 2022 | $44,696,000 | -35.7% | 4,906,266 | +5.2% | 0.03% | -29.2% |
| Q4 2021 | $69,554,000 | -24.9% | 4,661,815 | +29.3% | 0.05% | -26.2% |
| Q3 2021 | $92,631,000 | -0.7% | 3,604,300 | +0.8% | 0.06% | +3.2% |
| Q2 2021 | $93,289,000 | +102.4% | 3,577,030 | +174.0% | 0.06% | +96.9% |
| Q1 2021 | $46,081,000 | +47.4% | 1,305,400 | +5.4% | 0.03% | +39.1% |
| Q4 2020 | $31,257,000 | – | 1,238,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |